Tian Junqiang, Washizawa Naohiro, Gu Li H, Levin Marc S, Wang Lihua, Rubin Deborah C, Mwangi Simon, Srinivasan Shanthi, Jones Dean P, Ziegler Thomas R
Nutrition and Health Science Program, Graduate School of Arts and Sciences, Emory University, Atlanta, GA 30322, USA.
J Nutr. 2007 Feb;137(2):320-5. doi: 10.1093/jn/137.2.320.
Glutathione (GSH) concentration affects cell proliferation and apoptosis in intestinal and other cell lines in vitro. However, in vivo data on gut mucosal GSH redox status and cell turnover are limited. We investigated the effect of altered GSH redox status on the ileal mucosa in a rat model of short bowel syndrome following massive small bowel resection (SBR). Rats underwent 80% mid-jejunoileal resection (RX) or small bowel transection (TX; as operative controls), with administration of either saline or D, L-buthionine-sulfoximine (BSO), a specific inhibitor of cellular GSH synthesis. Ileal mucosal redox, morphology, and indices of cell proliferation and apoptosis were determined at different days after surgery. Ileal GSH redox status was assessed by GSH and GSH disulfide (GSSG) concentrations and the redox potential of GSH/GSSG (Eh). Ileal lipid peroxidation [free malondialdehyde (MDA)] was measured as an index of lipid peroxidation. BSO markedly decreased ileal mucosal GSH, oxidized GSH/GSSG Eh, and increased MDA content without inducing morphological damage as assessed by light or electron microscopy. As expected, SBR stimulated adaptive growth of ileal villus height and total mucosal height at 7 d after surgery, but this response was unaffected by BSO treatment despite a modest increase in crypt cell apoptosis. Ileal cell proliferation (crypt cell bromodeoxyuridine incorporation) increased at 2 d after SBR but was unaffected by BSO. Collectively, our in vivo data show that marked depletion of ileal GSH and oxidation of the GSH redox pool does not alter indices of ileal epithelial proliferation or SBR-induced ileal mucosal adaptive growth.
谷胱甘肽(GSH)浓度在体外影响肠道及其他细胞系的细胞增殖和凋亡。然而,关于肠道黏膜GSH氧化还原状态和细胞更新的体内数据有限。我们在大鼠大规模小肠切除术后短肠综合征模型中,研究了GSH氧化还原状态改变对回肠黏膜的影响。大鼠接受80%的空肠回肠中段切除术(RX)或小肠横断术(TX;作为手术对照),并给予生理盐水或D,L-丁硫氨酸-亚砜胺(BSO,一种细胞内GSH合成的特异性抑制剂)。在术后不同天数测定回肠黏膜的氧化还原状态、形态以及细胞增殖和凋亡指标。通过GSH和谷胱甘肽二硫化物(GSSG)浓度以及GSH/GSSG的氧化还原电位(Eh)评估回肠GSH氧化还原状态。测量回肠脂质过氧化[游离丙二醛(MDA)]作为脂质过氧化的指标。通过光学或电子显微镜评估,BSO显著降低回肠黏膜GSH、氧化型GSH/GSSG Eh,并增加MDA含量,但未诱导形态学损伤。正如预期的那样,小肠切除术后7天,SBR刺激回肠绒毛高度和总黏膜高度的适应性生长,但尽管隐窝细胞凋亡略有增加,这种反应不受BSO治疗的影响。小肠切除术后2天回肠细胞增殖(隐窝细胞溴脱氧尿苷掺入)增加,但不受BSO影响。总体而言,我们的体内数据表明,回肠GSH的显著耗竭和GSH氧化还原池的氧化不会改变回肠上皮增殖指标或SBR诱导的回肠黏膜适应性生长。